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TransplantatABSTRACT
Background. Fungal infections are a rare but important cause of morbidity and mortality
in kidney transplantation. Fungal contamination of the kidney preservation ﬂuid may,
sometimes, be the cause of these infections. However, the clinical consequences of fungal
contamination of this ﬂuid are not completely understood and literature on this topic is
controversial. The purpose of this study was to determine the incidence of preservation
ﬂuid contamination by fungi and its clinical consequences.
Methods. From June 2010 to September 2011, a prospective cohort analysis was con-
ducted at our center, enrolling all patients who received a renal allograft and whose
perfusion ﬂuid was analyzed for microbiology sterility. Patients with perfusion ﬂuids
positive for fungi were further studied: the patients’ status was assessed during regular visits
and data were recorded, including clinical characteristics, infections, graft function,
immunosuppressive regimen and outcomes.
Results. Microbiologic, cultures of 70 kidney perfusion ﬂuids using speciﬁc mycologic
media, obtained from 74 cadaveric renal transplants (4 ﬂuids were unsuitable for analysis),
were evaluated. Six samples were positive for yeasts (8.6%), with 4 isolates of Candida
albicans and 2 isolates of Candida glabrata. Four patients had no evidence of fungal
infection during the follow-up period (median 321 days); conversely, 2 patients developed
severe mycotic vascular complications leading to transplantectomy.
Conclusions. Perfusion ﬂuid contamination by fungi is an elusive situation that can lead
either to an unremarkable clinical course or to graft loss life-threatening situations.
Routine culture of kidney perfusion ﬂuid is critical for prompt diagnosis and early
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Amadora, Portugal. E-mail: bfgrodrigues@gmail.comINFECTIOUS COMPLICATIONS are an importantcause of morbidity and mortality in patients undergoing
renal transplantation.1 Despite the decreasing incidence,
fungal infections still affect 5% of renal transplant recipi-
ents.2,3 Yeast infections generally occur in the ﬁrst 3 months
after transplantation, with a wide range in severity, from
simple mucocutaneous infections to life-threatening condi-
tions.2 Contamination of the preservation ﬂuid is probably
an independent factor leading to donor kidney contamina-
tion. Exogenous contamination during recovery and
handling of the graft has been suggested as a possible source
of these infections, with several cases reported.4e8 Accord-
ingly, Albano et al presented a study that strongly suggests
that organ contamination was the consequence of perito-
neal donor contamination in at least 9 of 12 cases.9lsevier Inc. All rights reserved.
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ion Proceedings, 45, 2215e2219 (2013)The prevalence of yeast contamination of kidney preser-
vation ﬂuid is variable. Botterel et al have recently pub-
lished a study with a prevalence of 3.1%, using plating
media speciﬁc for yeasts.5 Other publications have reported
different frequencies (2%e10%), although some authors did0041-1345/13/$esee front matter
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2216 RODRIGUES, NATÁRIO, VIZINHO ET ALnot use speciﬁc yeast culture media.10,11 Botterel et al called
attention to the fact that only 28.5% cases were identiﬁed
when routine bacteriologic methods were used as compared
to the yield obtained when speciﬁc mycologic procedures
were used.5
The clinical consequences of yeast contamination of
preservation ﬂuid are not completely understood and data
are conﬂicting. Candida sp have been related to serious
complications mainly by compromising the vascular anas-
tomosis with mycotic arteritis and aneurism. Facing lethal
events, some authors have recommended preventive
nephrectomy when yeast contamination of preservation
ﬂuid is identiﬁed.10 Others have suggested a more conser-
vative approach, since factors predisposing patients to
adverse events are not yet established and conservative
strategies have also achieved acceptable results.5,11e13
The purpose of this prospective analysis is to determine
the frequency of preservation ﬂuid contamination by fungi
and its clinical consequences.MATERIALS AND METHODS
In this prospective analysis, samples of the preservation ﬂuid from
kidney transplantation procedures performed at our center were
analyzed, and all patients culture-positive for fungi were selected.
Samples were collected immediately prior to the back-table
dissection of the kidney. One 5-mL sample of the perfusion ﬂuid
was taken from the bag containing the kidney and was immediately
inoculated into an aerobic blood culture bottle from BacT/Alert
automated system (BioMerieux) and sent to the microbiology
laboratory. There, 5 mL of sterile blood was added to the bottle and
only then it was loaded in the BacT/Alert equipment that is a system
of continuous monitoring of blood cultures for detecting bacteremia
and fungemia. In positive bottles, 1 mL of ﬂuid was aseptically
removed and platted in a blood-gelose plate incubated at 37C for
48 hours. Candida identiﬁcation was done by the automated system
Vitek2 (bioMerieux). The patient’s status was assessed during
regular outpatient’s clinic visits, and data, including clinical char-
acteristics, infections, graft function, immunosuppressive regimen,
and mortality, were recorded. Patients had a minimum follow-up of
114 days.RESULTS
Eighty-nine kidney transplants (74 cadaveric and 15 living
donors) were performed in 88 recipients, at the Renal
Transplantation Department of Hospital de Santa Cruz,
Lisbon, Portugal, between June 2010 and September 2011.
Seventy samples of kidney preservation ﬂuids (all but 4,
whose samples were unsuitable for culture) were collected
from the 74 cadaveric renal allografts. Six of these samples
(incidence of 8.6%) were positive for yeasts: 4 grew Candida
albicans and 2 grew Candida glabrata. Samples from patient
2 and 3 also showed the presence of Streptococcus gordoni
and Staphylococcus epidermidis. The incidence of bacterial
contamination in the study was 67.1%.
The characteristics of the donor, recipient, histocompat-
ibility, and immunosuppression are shown in Table 1. Note
that allografts from patient 5 and 6 were collected from thesame donor. However, allografts from the 2 patients with
vascular complications (4 and 6) came from different
donors. Microbiologic data for the preservation ﬂuid
samples, posttransplantation data, and outcome are pre-
sented in Table 2.
All patients received antibiotic prophylaxis at the moment
of transplantation with cephazoline (2 g intravenous, single
dose). Induction immunosuppression was not uniform
among the patients. Every patient received maintenance
immunosuppression with tacrolimus, mycophenolate mofe-
til, and prednisone adjusted to weight.
Four of the 6 patients who received kidneys from positive
isolates showed no clinical signs of fungal infection during
the follow-up period (median 321 days; range 114e528
days).
Patients with C albicans presented higher hospitalization
periods when compared to those with C glabrata (11 vs 21.5
days). Three of the 4 recipients with C albicans presented
delayed graft function. Two patients (recipients 4 and 6),
both with C albicans isolation in the preservation ﬂuid,
developed serious vascular complications.
Recipient 4 was admitted 37 days after transplantation
with severe abdominal pain and hypotension shortly fol-
lowed by cardiorespiratory arrest. Successful resuscitation
was followed by emergency surgery, which revealed the
rupture of an aneurysmal dilatation of the renal artery and
a large hemoperitoneum, requiring transplantectomy and
iliofemoral bypass. Blood and urine cultures were negative
before and after the incident. Histologic examination of the
graft specimen showed tubular necrosis and inﬂammatory
interstitial inﬁltration. The renal artery presented internal
elastic lamina duplication and atheroma (the aneurysmatic
portion of the artery was not available either for histologic
or for microbiology exam). The patient was treated with
ﬂuconazole 100 mg (ﬁrst intravenously and then orally) for
20 days and was discharged on hemodialysis. The patient-
recipient pair was also transplanted in our unit. His perfu-
sion ﬂuid cultures were negative and did not revealed any
complications.
Patient 6 had a prolonged hospitalization after trans-
plantation due to delayed graft function and bacteremia
caused by methicillin-resistants epidermidis. The patient was
discharged with no signs of infection and with a serum
creatinine value of 1.5 mg/dL. This patient was readmitted 1
week later with an asymptomatic increase in serum creati-
nine level to 5.09 mg/dL. Doppler ultrasound was per-
formed and showed a low resistive index (0.6e0.65). The
computed tomography (CT) scan and angiography per-
formed revealed an aneurysmatic dilatation in one of the
allograft arteries, responsible for the compression of the
second allograft artery, limiting its blood ﬂow. Intravascular
stent grafting was tried but placement was unsuccessful.
Surgical aneurysm repair was performed and tissue culture
revealed the presence of C albicans. Liposomic amphoter-
icin B therapy was initiated at a dose of 5 mg/kg/d and
maintained for 27 days and then switched to voriconazole
200 mg twice a day. These measures were not successful and
Table 1. Characteristic of the Donor, Recipient, Transplantation, and Immunosuppression
1 2 3 4 5 6
Donor
Age (y) 58 62 66 50 4
Gender F F F M M
Cause of death HE HE HE HE Drowning
Recipient
Age (y) 49 57 63 29 17 49
Gender M F M F F M
Transplantation
HLA mismatch 2 6 6 4 5 2
Anti-HLA (%) 0 0 0 11 0 0
Number
arteries/veins
1/1 1/1 1/1 1/1 1/1 2/1
Cold Ischemia (h) 17 17 22 19 15 21
Immunosuppression
Induction Basiliximab ATG Basiliximab ATG þ IVIG þ RIT Basiliximab Basiliximab
Maintenance CNI þMMF þ Pred CNI þMMF þ Pred CNI þ MMF þ Pred CNI þMMF þ Pred CNI þMMF þ Pred CNI þ MMF þ Pred
HE, hemorrhagic stroke; CNI, calcineurin inhibitors; MMF, mycophenolate mofetil; Pred, prednisolone; ATG, antithymocyte globulin; IVIG, Intravenous immuno-
globulin; RIT, Rituximab; HLA, human leukocyte antigen.
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after transplantation), with hypovolemic shock. Trans-
plantectomy was performed with the need for a cross-
femoro-femoral bypass. After surgery, the patient became
febrile. Blood and urine cultures were negative, antifungal
therapy was maintained, and vancomycin and meropenem
were added. Thoracic and abdominal CT scans were
suggestive of multiple infectious foci spread within the
abdomen and lungs. The patient had a prolonged hospital-
ization period under antibiotic and antifungal therapy, being
stable at the moment, under hemodialysis therapy.
Concerning allograft function, at the end of the study, 2
of the 6 patients were dialysis-dependent and the remaining
4 patients had functional allografts, with a median estimated
glomerular ﬁltration rate (MDRD) of 49 mL/min/1.73 m2
(range: 33e88 mL/min/1.73 m2).Table 2. Preservation Fluid Microbiologic Resul
1 2
Preservation ﬂuid testing Candida glabrata C glabrata
Streptococu
Antifungal treatment No No
Hospitalization (d) 12 10
Delayed graft function No No
SCr at hospital discharge (mg/dL) 1.9 1.4
Periallograft ﬂuid collection No No
Angio CT/angiography Renal artery stricture d
Outcome
Follow-up (d) 528 471
Last SCr value (mg/dL) 1.7 1.6
GFReMDRD (mL/min/1.73 m2) 43 33
Anastomotic rupture No No
Day after transplantation d d
SCr, serum creatinine; GFReMDRD, glomerular ﬁltration rate estimated with MD
tomography.DISCUSSION
Graft handling and exposure to contaminants during organ
recovery has been considered the most probable cause for
fungal contamination, especially in recovery of multiple-
organ transplantations. This hypothesis was reinforced by
Albano et al, using genetic analysis to correlate organ and
perfusion ﬂuid contamination with peritoneal contamina-
tion of the donor.9,10
The incidence of yeast contamination is lower than
bacterial contamination, but severe adverse events have
been reported.9e11,14e19 During our study period, 6 of the 70
samples (incidence of 8.6%) showed contamination with
Candida spp, a similar value reported in other series (range
1.7%e9.6%).5,10e19
We used an automated broth culture system for micro-
biologic analysis. Comparison between series is difﬁcultts, Post-transplantation Datas and Outcome
3 4 5 6
s
Candida
glabrata
Streptococus
epidermidis
C albicans C albicans C albicans
No Yes Prophylaxis Yes
14 27 13 32
No Yes Yes Yes
2.2 2.0 2.0 1.5
No Yes Yes No
d d d Renal artery
pseudoaneurysm
487 212 114 114
1.6 HD 1.0 HD
33 d 88 d
No Yes No Yes
d 37 d 59
RD formula; HD, hemodialysis; ATN, acute tubular necrosis; CT, computed
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applied. Botterel et al mentioned that the use of broth
culture techniques were superior to direct plating methods,
although even this method can underestimate the true
incidence of yeast contamination. The same author showed
that routine bacterial culture media identiﬁed only 5 of the
21 fungal contaminants detected when plating in media
speciﬁc for fungi. This ﬁnding may indicate the existence of
competition between yeasts and bacteria or reﬂect the
different incubation conditions used.5
The clinical consequences of fungal contamination of
preservation ﬂuid are not completely clariﬁed, since
different outcomes have been published in small series. The
most frequent severe adverse advents that have been
registered are vascular complications, namely mycotic
aneurysms and anastomotic rupture.6e8,20e22
Using a conservative strategy Botterel et al, and Man-
tignon et al, Canaud et al showed that in a total 27
recipients, none developed vascular complications.5,12,13 On
the other hand, several authors reported the occurrence of
aneurysmatic lesions and anastomotic rupture related to C
albicans contamination of preservation ﬂuid.7e9 Veroux et al
had also published an interesting case of acute renal failure
30 days after transplantation due to ureteral obstruction by
a fungus ball in a patient positive for C albicans in perfusion
ﬂuid.23 Our study unveils a large range of events, from
patients with no adverse outcome (4 patients) to patients
with aneurysmatic development and anastomotic rupture
(2 patients) on days 37 and 59 after transplantation (none of
them receiving any antifungal prophylactic therapy). In both
cases, C albicans was involved.
To our knowledge C albicans was also the only yeast
implicated in other cases with vascular complica-
tions.6e8,21,22 This phenomenon may be explained by the
ability of C albicans to adhere, invade, and damage human
vascular endothelial cells.24,25
Our affected patients showed clinical presentations similar
to those previously described in the literature: some patients
have an abrupt onset with hypovolemic shock requiring
emergency surgery, while others have a more indolent course
with fever or worsening renal function and imaging tech-
niques revealing structural arterial lesions.6e9,21,22 The long
evolution period could be considered important to allograft
salvage, even though Bracale et al have reported disap-
pointing outcomes: from 6 patients with large anastomotic
pseudoaneurysm, 5 had open repair and 1 stent grafting.
Nevertheless, transplantectomy was necessary in 5 cases.20
The establishment of a causal relationship between C
albicans contamination of perfusion ﬂuid and later vascular
complications in the transplant recipient is not always
unequivocal. Efforts should be made to establish a microbi-
ologic or histologic link. In case 4, due to the cataclysmic
presentation, emergency transplantectomy was performed
and the visualized aneurysmal lesion was not properly
sampled nor was it sent for microbiologic evaluation. The
histopathology only reported inﬂammatory inﬁltration of
the arterial pedicle. In patient 6 it was possible to performmicrobiologic exam of the vascular lesion, which revealed
the presence of C albicans; the histology showed ﬁbrinoid
necrosis of the arterial wall. In both patients, blood and
urine cultures done before and after transplantectomy were
negative for fungus. Similar situations have also been re-
ported by other authors. Albano et al reported positive
cultures in 8 of 11 arterial specimens, but in only 2 of 11
recipients the blood cultures were positive.9 Renal arteritis
cannot be ruled out in the absence of candidemia or
candiduria.
The approach to these patients must be stratiﬁed and 2
situations must be considered in kidney recipients with
perfusion ﬂuid contaminated with fungi: those with and
those without signs of arterial allograft lesion, since the
prognosis varies dramatically between these 2 groups. Mai
et al suggested that nephrectomy should be done in cases in
which the preservation ﬂuid is contaminated with Candida
spp, even though, as seen in our series and in recently
published by others, Candida contamination not always
leads to an unfavorable outcome.5,8,12,13
Appropriate antifungal prophylactic therapy has not been
determined yet, and centers are applying different
approaches, ranging from no therapy to therapy with 2 drugs
for at least 3 months.9,13 When a renal artery aneurysm is
detected, the end result is almost invariably allograft
removal.6e9,20
In Conclusion, perfusion ﬂuid contamination in our
sample occurred in 6 of 70 samples (incidence of 8.6%).
Based on our current experience and the published litera-
ture, we conclude that: (1) kidney perfusion ﬂuid should
always be analyzed for sterility; (2) a positive result for C
albicans should always prompt speciﬁc prophylactic therapy
and close monitoring with ultrasound and Doppler scan; (3)
if vascular injury is detected by ultrasound, conﬁrmation by
angiography or CT scan should be performed and allograft
removal should be strongly considered.
Perfusion ﬂuid contamination by fungi is an elusive situ-
ation that can lead either to an unremarkable clinical course
or to graft loss life-threatening situations. Understanding
the pathophysiology of fungal renal arteritis is mandatory to
create adequate prevention and prophylaxis strategies.
Although rare, serious life-threatening vascular complica-
tions occur.
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